(Q34746349)

4 August 2017

1 reference

title

The rational management of fibromyalgia patients (English)

1 reference

4 August 2017

0 references

Robert M Bennett

1

0 references

publication date

1 May 2002

1 reference

Rheumatic Diseases Clinics of North America

4 August 2017

1 reference

4 August 2017

28

1 reference

4 August 2017

2

1 reference

4 August 2017

181-99, v

1 reference

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

The concurrence of lupus and fibromyalgia: implications for diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Determinants of WOMAC function, pain and stiffness scores: evidence for the role of low back pain, symptom counts, fatigue and depression in osteoarthritis, rheumatoid arthritis and fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

How important is patient education?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Education programmes for fibromyalgia patients: description and evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

A randomized, controlled trial of exercise and education for individuals with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Self-efficacy and outcome expectancies: relationship to chronic pain coping strategies and adjustment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Effects of a three-year exercise program on motor function and cognitive processing speed in older women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Is there muscle pathology in fibromyalgia syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Dorsal horn neurophysiology of pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Spinal cord pharmacology of pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Pain mechanisms and management: a central perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Pain: its physiology and rationale for management. Part I. Neuroanatomical substrate of pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Neuroanatomy of the pain system and of the pathways that modulate pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

NK1 (substance P) receptor antagonists--why are they not analgesic in humans?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Effects of extraversion and neuroticism on experimental pain, clinical pain, and illness behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Sensory-affective relationships among different types of clinical and experimental pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Pain affect encoded in human anterior cingulate but not somatosensory cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

The role of psychological factors in chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

"Unexplained" somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Alertness-enhancing drugs as a countermeasure to fatigue in irregular work hours.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Clustering of sleep electroencephalographic patterns in patients with the fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Induction of Neurasthenic Musculoskeletal Pain Syndrome by Selective Sleep Stage Deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Zopiclone in the treatment of sleep abnormalities in fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Treatment of periodic leg movement disorder and restless leg syndrome with talipexole.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Restless legs syndrome improved by pramipexole: a double-blind randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

The role of psychological factors in chronic pain. II. A critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Relationship between the chronic pain grade and measures of physical, social and psychological well-being

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Comorbidity of fibromyalgia with medical and psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Antidepressant treatment of fibromyalgia. A meta-analysis and review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

The neuroscience and endocrinology of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

The connection between chronic fatigue syndrome and neurally mediated hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

The postural orthostatic tachycardia syndrome: a potentially treatable cause of chronic fatigue, exercise intolerance, and cognitive impairment in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Serotonin and central nervous system function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Perception of pain following aerobic exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Beta-endorphin response to exercise. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Analgesia following exercise: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Changes in beta-endorphin levels in response to aerobic and anaerobic exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

The Contribution of Muscle to the Generation of Fibromyalgia Symptomology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

The fibromyalgia syndrome: musculoskeletal pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Memory functioning in patients with primary fibromyalgia and major depression and healthy controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Cognitive dysfunction in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Concentration and memory deficits in patients with fibromyalgia syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Suffering: the contributions of persistent pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Bowel dysfunction and irritable bowel syndrome in fibromyalgia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Irritable bowel syndrome: new pharmaceutical approaches to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Symptoms of Raynaud's syndrome in patients with fibromyalgia. A study utilizing the Nielsen test, digital photoplethysmography, and measurements of platelet α2-adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Lack of correlation between the mean tender point score and self-reported pain in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

Treating fibromyalgia with a brief interdisciplinary program: initial outcomes and predictors of response

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900002-9

7 January 2021

10.1016/S0889-857X(02)00002-9

Identifiers

DOI

1 reference

release_haijjvwpfzcoxiddxb5lj54ve4

4 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/haijjvwpfzcoxiddxb5lj54ve4

24 November 2022

mapped directly with Wikidata item

PubMed ID

12122913

1 reference

PubMed ID

12122913